<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://localhost:8080/xmlui/handle/123456789/1101">
    <title>DSpace Collection:</title>
    <link>http://localhost:8080/xmlui/handle/123456789/1101</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/2855" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/2854" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/2851" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/2849" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-09T23:02:26Z</dc:date>
  </channel>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/2855">
    <title>Prevention and Treatment of Venous Thromboembolism in Pregnancy</title>
    <link>http://localhost:8080/xmlui/handle/123456789/2855</link>
    <description>Title: Prevention and Treatment of Venous Thromboembolism in Pregnancy
Authors: Suparman, Erna
Abstract: Prevention and Treatment of Venous Thromboembolism in Pregnancy&#xD;
Pencegahan dan Tatalaksana Tromboemboli Vena pada Kehamilan&#xD;
Erna Suparman&#xD;
Department of Obstetrics and Gynecology&#xD;
Faculty of Medicine Sam Ratulangi University&#xD;
 Prof. Dr. R. D. Kandou General Hospital&#xD;
Manado, North Celebes&#xD;
Abstract&#xD;
Abstrak&#xD;
Objective: To determine prevention and treatment of&#xD;
venous thromboembolism in pregnancy.&#xD;
Tujuan: Mengetahui bagaimana pencegahan dan tatalaksana tromboemboli vena pada&#xD;
kehamilan.&#xD;
Methods: Literature Review.&#xD;
Results: The diagnosis of TEV, both deep vein thrombosis&#xD;
(DVT) and pulmonary embolism (PE) was clinical and&#xD;
conﬁ rmed by imaging. D-dimers commonly used in the&#xD;
non-pregnant population are less useful in pregnant&#xD;
women. Prevention needs to be done by assessing the risk&#xD;
of TEV in pregnant women and giving thrombophylaxis&#xD;
according to risk. Treatment of TEV in pregnant women&#xD;
mainly uses heparin, either unfractionated heparin (UFH) or&#xD;
low molecular weight heparin (LMWH).&#xD;
Conclusion: The ASH recommends the use of LMWH&#xD;
compared with UFH for the management of acute&#xD;
VTE in pregnancy, in once-daily or divided doses. The&#xD;
recommended method of delivery for pregnant women&#xD;
receiving anticoagulant therapy should be planned delivery.&#xD;
Keywords: vein thromboemboli, deep vein thrombosis,&#xD;
pulmonary embolism, pregnancy.&#xD;
Metode: Kajian Pusataka.&#xD;
Hasil: Diagnosis TEV, baik Deep vein thrombosis (DVT)&#xD;
dan pulmonary embolism (PE) berdasarkan klinis dan&#xD;
dikonﬁ rmasi dengan pencitraan. D-dimer yang biasa&#xD;
digunakan pada populasi non-hamil kurang berguna pada&#xD;
ibu hamil. Pencegahan perlu dilakukan dengan menilai risiko&#xD;
TEV pada ibu hamil dan memberikan tromboﬁ laksis sesuai&#xD;
dengan risiko. Tatalaksana TEV pada ibu hamil terutama&#xD;
menggunakan heparin, baik unfractionated heparin (UFH)&#xD;
maupun low molecular weight heparin (LMWH).&#xD;
Kesimpulan: ASH merekomendasikan penggunaan LMWH&#xD;
dibandingkan dengan UFH untuk pengelolaan VTE akut&#xD;
pada kehamilan, dalam dosis sekali sehari atau terbagi.&#xD;
Metode persalinan yang direkomendasikan untuk ibu hamil&#xD;
yang menerima terapi antikoagulan harus direncanakan&#xD;
persalinan.&#xD;
Kata kunci: tromboemboli vena, deep vein thrombosis,&#xD;
pulmonary embolism, kehamilan.</description>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/2854">
    <title>Treatment Approach for a Rare Case of Cervical Cancer in Pregnancy</title>
    <link>http://localhost:8080/xmlui/handle/123456789/2854</link>
    <description>Title: Treatment Approach for a Rare Case of Cervical Cancer in Pregnancy
Authors: Putri, Yuannita I.; Wiranegara, Gumilang
Abstract: Treatment Approach for a Rare Case of Cervical Cancer in Pregnancy&#xD;
Pendekatan Terapi pada Kanker Serviks dalam Kehamilan&#xD;
Yuannita I. Putri, Gumilang Wiranegara&#xD;
Badan Pengusahaan Batam Hospital&#xD;
Batam&#xD;
Abstract&#xD;
Abstrak&#xD;
Objective: To add a new overview of cervical cancer in&#xD;
pregnancy and to review several treatment approaches&#xD;
using available guidelines.&#xD;
Tujuan: Untuk menambah gambaran kasus mengenai kanker&#xD;
serviks dalam kehamilan serta membahas pendekatan terapi&#xD;
menggunakan pedoman – pedoman yang ada. &#xD;
Methods: Case report.&#xD;
Case: A 29 years old woman, gravida 3 para 2 in 10 weeks of&#xD;
pregnancy, was presented with vaginal bleeding and bloody&#xD;
vaginal discharge. Ultrasound examination showed a 10&#xD;
weeks single live intrauterine fetus and a mass on the cervix.&#xD;
The histopathological report revealed a poorly differentiated&#xD;
cervical adenocarcinoma without invasion of lymphovascular&#xD;
space. Patient was diagnosed with cervical carcinoma FIGO&#xD;
stage IB3 in 10 weeks of pregnancy. The patient opted to&#xD;
unpreserved the pregnancy. Radical hysterectomy with fetus&#xD;
in situ and bilateral pelvic lymphadenectomy was performed.&#xD;
Patient was referred to undergo adjuvant radiation therapy.&#xD;
Conclusion: Cervical cancer in pregnancy is a rare and&#xD;
special condition that requires individual planning for the&#xD;
diagnostic and treatment approaches.&#xD;
Keywords: cervical cancer, cervical cancer in pregnancy,&#xD;
fetus in situ hysterectomy, pregnancy,  radical hysterectomy. &#xD;
Metode: Laporan kasus.&#xD;
Kasus: Seorang perempuan berusia 29 tahun dengan&#xD;
G3P2 usia kehamilan 10 minggu datang dengan keluhan&#xD;
perdarahan pervaginam dan keputihan bercampur darah.&#xD;
Hasil dari USG menunjukkan adanya janin berusia 10&#xD;
minggu serta massa pada serviks. Hasil pemeriksaan&#xD;
histopatologi menunjukkan adanya adenokarsinoma&#xD;
serviks berdiferensiasi buruk tanpa invasi limfovaskuler.&#xD;
Pasien didiagnosis dengan kanker serviks stadium FIGO IB3&#xD;
dalam kehamilan 10 minggu. Pasien setuju untuk dilakukan&#xD;
terminasi kehamilan. Pada pasien kemudian dilakukan&#xD;
laparotomi histerektomi radikal dengan fetus in situ serta&#xD;
limfadenektomi pelvik bilateral. Pasien kemudian dirujuk&#xD;
untuk dilakukan terapi ajuvan dengan radiasi.  &#xD;
Kesimpulan: Kanker serviks pada kehamilan merupakan&#xD;
suatu kondisi khusus sehingga perencanaan diagnostik&#xD;
dan manajemen terapi membutuhkan perencanaan secara&#xD;
individual di setiap kasusnya.&#xD;
Kata kunci: Kanker, kanker serviks, kanker serviks dalam&#xD;
kehamilan,  kehamilan, , histerektomi radikal, histerektomi&#xD;
dengan fetus in situ.</description>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/2851">
    <title>High Random Blood Glucose Level before Surgery as a Risk Factor for Recurrent Event in Epithelial Ovarian Carcinoma</title>
    <link>http://localhost:8080/xmlui/handle/123456789/2851</link>
    <description>Title: High Random Blood Glucose Level before Surgery as a Risk Factor for Recurrent Event in Epithelial Ovarian Carcinoma
Authors: Hapsari, Anggiyasti V.; Iskandar, Teuku M.
Abstract: High Random Blood Glucose Level before Surgery as a Risk Factor&#xD;
for Recurrent Event in Epithelial Ovarian Carcinoma&#xD;
Kadar Gula Darah Sewaktu yang Tinggi sebelum Operasi sebagai Faktor Risiko&#xD;
Kejadian Residif pada Pasien Karsinoma Ovarium Tipe Epitelia&#xD;
Anggiyasti V. Hapsari, Teuku M. Iskandar&#xD;
Department of Obstetrics and Gynecology&#xD;
Faculty of Medicine Universitas Diponegoro&#xD;
Dr. Kariadi General Hospital &#xD;
Semarang&#xD;
Abstract&#xD;
Abstrak&#xD;
Objective: To investigate the high random blood glucose&#xD;
level as a risk factor for recurrent disease in EOC patient at&#xD;
Kariadi General Hospital.&#xD;
Tujuan: Untuk membuktikan kadar glukosa darah sewaktu&#xD;
yang tinggi sebagai faktor risiko kejadian residif pada pasien&#xD;
karsinoma ovarium epitelial di RSUP dr. Kariadi.&#xD;
Methods: Sixty six patients diagnosed as EOC in Kariadi&#xD;
General Hospital were divided into 2 groups: 30 patients&#xD;
with recurrent disease and 30 patients without recurrent&#xD;
disease after completing chemotherapy cycles. We analysed&#xD;
correlation between age of diagnosis, tumour mass location,&#xD;
Ca-125 level, histological subtype and random blood&#xD;
glucose level before surgery with recurrent disease.&#xD;
Metode: Enam puluh pasien yang telah didiagnosis sebagai&#xD;
karsinoma ovarium epitelial di RSUP dr. Kariadi dibagi&#xD;
menjadi 2 kelompok: 30 pasien pada kelompok residif dan&#xD;
30 pasien pada kelompok non-residif berdasarkan evaluasi&#xD;
setelah menyelesaikan siklus kemoterapi. Data yang&#xD;
dianalisis meliputi usia saat terdiagnosis, lokasi tumor, kadar&#xD;
Ca-125, subtipe histologi, kadar gula darah sewaktu (GDS)&#xD;
sebelum operasi dan hubungannya dengan kejadian residif.&#xD;
Results: There is no signiﬁ cantly difference in age of&#xD;
diagnosis, tumour mass location and histological subtypes&#xD;
between two groups. However, recurrent EOC patients have&#xD;
higher Ca-125 level signiﬁ cantly than non-recurrent patients&#xD;
(327.8±250.5 vs 183.5±212.1 respectively; p = 0,01). Mean&#xD;
of random blood glucose level of recurrent patients is also&#xD;
higher than non-recurrent patients signiﬁ cantly (150.5 ±79&#xD;
vs 110.8 ± 31.1 respectively; p = 0.006). Patient with random&#xD;
blood glucose level &gt; 110 mg/dl have 3 times more likely to&#xD;
develop recurrence in EOC patient signiﬁ cantly with 95% CI.&#xD;
Hasil: PTidak terdapat perbedaan yang bermakna dalam&#xD;
usia saat diagnosis, lokasi tumor dan subtipe histologis&#xD;
diantara kedua kelompok. Namun, kelompok pasien residif&#xD;
memiliki kadar Ca-125 yang lebih tinggi secara bermakna&#xD;
dibandingkan kelompok pasien non-residif (327,8 ± 250,5 vs&#xD;
183,5 ± 212,1; p = 0,01). Rerata kadar GDS pada kelompok&#xD;
pasien residif juga lebih tinggi secara bermakna daripada&#xD;
kelompok non-residif (150,5 ± 79 vs 110,8 ± 31,1; p = 0,006).&#xD;
Pasien dengan kadar GDS &gt; 110 mg/dl memiliki risiko 3 kali&#xD;
lipat untuk menjadi residif secara bermakna dengan tingkat&#xD;
kepercayaan 95%. &#xD;
Conclusion: The mean of random blood glucose level in&#xD;
recurrent EOC patients is signiﬁ cantly higher than nonrecurrent EOC patients. Patient with random blood glucose&#xD;
&#xD;
level &gt; 110 mg/dl have 3 times more likely to develop&#xD;
&#xD;
recurrence in EOC&#xD;
patient.&#xD;
Kesimpulan: Rerata kadar GDS pada kelompok pasien&#xD;
residif lebih tinggi secara bermakna dibanding kelompok&#xD;
pasien non-residif. Pasien dengan kadar GDS &gt; 110 mg/dl&#xD;
memiliki risiko 3 kali lipat untuk menjadi residif.&#xD;
Keywords: cepithelial ovarian cancer, random blood&#xD;
glucose level, recurrent.&#xD;
Kata kunci: kadar gula darah sewaktu, karsinoma ovarium&#xD;
epitelial, residif.</description>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/2849">
    <title>The Efﬁcacy of Chemotherapy in Advanced-Stage Cervical Cancer on Vitamin A Serum</title>
    <link>http://localhost:8080/xmlui/handle/123456789/2849</link>
    <description>Title: The Efﬁcacy of Chemotherapy in Advanced-Stage Cervical Cancer on Vitamin A Serum
Authors: Nurwany, Raissa; Sanif, Rizal; Noviliani, Amirah; Theodorus, Theodorus
Abstract: The Efﬁ cacy of Chemotherapy in Advanced-Stage Cervical&#xD;
Cancer on Vitamin A Serum&#xD;
Efektivitas Kemoterapi pada Karsinoma Serviks Stadium Lanjut&#xD;
terhadap Serum Vitamin A&#xD;
Raissa Nurwany, Rizal Sanif, Amirah Noviliani, Theodorus&#xD;
Department of Obstetrics and Gynecology&#xD;
Faculty of Medicine Universitas Sriwijaya&#xD;
Dr. Mohammad Husein General Hospital&#xD;
Palembang&#xD;
Abstract&#xD;
Abstrak&#xD;
Objective: To determine the efﬁ cacy of neoadjuvant&#xD;
chemotherapy on changes of vitamin A serum in advanced&#xD;
cervical carcinoma patient.&#xD;
Tujuan: Untuk mengetahui efektivitas kemoterapi&#xD;
neoadjuvan terhadap perubahan kadar serum vitamin A&#xD;
pada karsinoma servik stadium lanjut.&#xD;
Methods: A randomized clinical trial was performed in&#xD;
the Oncology Gynecology Polyclinic and Ward of Dr.&#xD;
Mohammad Hoesin General Hospital, Palembang from&#xD;
September 2019 to September 2020. There were 30 subjects&#xD;
of advanced cervical carcinoma. Vitamin A levels and tumor&#xD;
volume subjects were assessed before and 1 month after&#xD;
3 cycles of NAC and analyzed using the Paired T Test and&#xD;
Wilcoxon test. The correlation between vitamin A levels and&#xD;
tumor volume was analyzed by using Spearman's Rho test.&#xD;
Data analysis was using SPSS version 22.0.&#xD;
Metode: Penelitian uji klinik tanpa pembanding telah&#xD;
dilakukan di Poliklinik dan Bangsal Onkologi Ginekologi&#xD;
RSUP Dr. Muhammad Hoesin Palembang sejak September&#xD;
2019 hingga September 2020. Didapatkan 30 sampel&#xD;
karsinoma serviks stadium lanjut. Kadar vitamin A dan&#xD;
volume tumor dinilai sebelum dan 1 bulan setelah 3 siklus&#xD;
NAC dan dianalsis menggunakan uji Paired T Test dan&#xD;
Wilcoxon. Korelasi antara Kadar vitamin A dan volume&#xD;
tumor sampel dianalisis menggunakan uji Spearman Rho’s.&#xD;
Analisa data menggunakan SPSS versi 22.0.&#xD;
Results: This study showed statistically not signiﬁ cant&#xD;
increase on vitamin A levels after 3 cycles of NAC&#xD;
chemotherapy (p=0.515). However, there was a signiﬁ cantly&#xD;
decrease in tumor volume after 3 cycles of NAC (p=0.000).&#xD;
In addition, there was a moderate negative correlation&#xD;
between tumor size and vitamin A (r=-0.475; p=0.008).&#xD;
Hasil: Pada penelitian ini terdapat peningkatan tidak&#xD;
signiﬁ kan kadar vitamin A setelah kemoterapi (p = 0,515).&#xD;
Terdapat penurunan secara signiﬁ kan volume tumor sebelum&#xD;
dan sesudah kemoterapi NAC 3 seri (p = 0,000).  Selain itu,&#xD;
didapatkan korelasi negatif sedang yang bermakna antara&#xD;
ukuran tumor dan kadar vitamin A ( r = -0,475 ; p = 0,008). &#xD;
Conclusion: It can be concluded that there was signiﬁ cantly&#xD;
decrease in tumor volume after 3 series NAC chemotherapy&#xD;
and the smaller tumor size, the higher level of vitamin A&#xD;
serum.&#xD;
Kesimpulan: Disimpulkan bahwa terdapat penurunan&#xD;
volume tumor setelah kemoterapi NAC 3 series dan semakin&#xD;
kecil ukuran tumor maka semakin tinggi kadar vitamin A&#xD;
dalam serum.&#xD;
Keywords: cervical cancer, neoadjuvant chemotherapy,&#xD;
randomized clinical trial, vitamin A.&#xD;
Kata kunci: kanker serviks, kemoterapi neoadjuvan, uji klinik&#xD;
tanpa pembanding, vitamin A.</description>
    <dc:date>2022-04-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

